M. Niewczas

发表

High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

A. Krolewski, J. Warram, E. Rosolowsky, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity.

P. Nyckowski, K. Zieniewicz, M. Krawczyk, 2003, Transplantation proceedings.

A Signature of Circulating Inflammatory Proteins and Development of End Stage Renal Disease in Diabetes

Jennifer K. Sun, Hetal S. Shah, C. Ware, 2019, Nature Medicine.

Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.

A. Galecki, J. Skupień, K. Duffin, 2018, Kidney international.

Liver transplantation in hepatitis C virus-related cirrhosis.

P. Nyckowski, K. Zieniewicz, M. Krawczyk, 2003, Transplantation proceedings.

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

T. Mayadas, X. Cullere, J. Skupień, 2012, Journal of the American Society of Nephrology : JASN.

Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy

Hetal S. Shah, D. Gordin, G. King, 2019, Diabetes Care.

Metabolomic Profiling in Individuals with a Failing Kidney Allograft

A. Secchi, P. Fiorina, L. Biancone, 2017, PloS one.

The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease

J. Skupień, A. Krolewski, M. Pezzolesi, 2012, Kidney international.

Increased plasma Kidney Injury Molecule-1 suggests early progressive renal decline in non-proteinuric patients with Type 1 diabetes

J. Skupień, J. Bonventre, A. Krolewski, 2015, Kidney international.

Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes

A. Krolewski, M. Niewczas, T. Gohda, 2014, Clinical and Experimental Nephrology.

Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria

J. Skupień, A. Krolewski, A. Doria, 2013, Diabetes Care.

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

J. Skupień, A. Krolewski, J. Warram, 2011, Journal of the American Society of Nephrology : JASN.

Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383–390

A. Krolewski, M. Niewczas, 2017, Diabetes Care.

Risk of ESRD and All Cause Mortality in Type 2 Diabetes According to Circulating Levels of FGF-23 and TNFR1

J. Skupień, A. Krolewski, W. Walker, 2013, PloS one.

Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes.

A. Krolewski, W. Walker, J. Warram, 2012, American journal of physiology. Renal physiology.

High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 Diabetes

A. Galecki, J. Weinberg, A. Krolewski, 2010, Diabetes Care.

Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy.

A. Krolewski, J. Warram, B. Perkins, 2008, Diabetes research and clinical practice.

Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics.

A. Krolewski, J. Warram, B. Perkins, 2008, Journal of the American Society of Nephrology : JASN.

Results of untargeted analysis using the SOMAscan proteomics platform indicates novel associations of circulating proteins with risk of progression to kidney failure in diabetes.

A. Galecki, R. Nelson, K. Duffin, 2022, Kidney international.

A Profile of Multiple Circulating TNF Receptors Associated with Early Progressive Renal Decline in Type 1 Diabetes: Similar to Profiles in Autoimmune Disorders

Hiroki, J. Skupień, B. Krolewski, 2020, Journal of the American Society of Nephrology.

Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type-1 diabetes

J. Klein, M. Merchant, A. Krolewski, 2013, Kidney international.

Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy?

P. Fiorina, A. Doria, M. Niewczas, 2012, Seminars in nephrology.

Serum Levels of Advanced Glycation Endproducts and Other Markers of Protein Damage in Early Diabetic Nephropathy in Type 1 Diabetes

A. Krolewski, N. Rabbani, A. Adaikalakoteswari, 2012, PloS one.

Synergism Between Circulating Tumor Necrosis Factor Receptor 2 and HbA1c in Determining Renal Decline During 5–18 Years of Follow-up in Patients With Type 1 Diabetes and Proteinuria

A. Galecki, J. Skupień, M. Małecki, 2014, Diabetes Care.

Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes

W. Knowler, R. Nelson, K. Lemley, 2015, Kidney international.

Comparison of the results of liver transplantation for elective versus urgent indications.

K. Dudek, P. Nyckowski, K. Zieniewicz, 2003, Transplantation proceedings.

[Enzymatic activity of cathepsin B, cathepsin B and L, plasmin, trypsin and collagenase in hepatocellular carcinoma].

J. Pawlak, L. Pączek, M. Niewczas, 2002, Polskie Archiwum Medycyny Wewnetrznej.

A biomimetic five-module chimeric antigen receptor (5MCAR) designed to target and eliminate antigen-specific T cells

T. Serwold, M. Niewczas, M. A. Thelin, 2020, Proceedings of the National Academy of Sciences.

Interleukin-10+ Regulatory B Cells Arise Within Antigen-Experienced CD40+ B Cells to Maintain Tolerance to Islet Autoantigens

L. Wen, M. Atkinson, R. Abdi, 2014, Diabetes.

Long-Term Heart Transplant Survival by Targeting the Ionotropic Purinergic Receptor P2X7

C. Ricordi, R. Abdi, A. Petrelli, 2013, Circulation.

Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes

A. Galecki, R. Nelson, K. Duffin, 2022, Science Translational Medicine.

Physical rehabilitation and risk of atherosclerosis after successful kidney transplantation.

M. Lewandowska, M. Niewczas, M. Lewandowska, 2006, Transplantation proceedings.

Acute liver transplant rejection: incidence and the role of high-doses steroids.

P. Nyckowski, K. Zieniewicz, M. Krawczyk, 2003, Transplantation proceedings.

Murine macrophages or their secretome delivered in alginate dressings enhance impaired wound healing in diabetic mice.

A. Veves, D. Mooney, Sahar Rahmani, 2022, Biomaterials.

Characterization of human invariant natural killer T cells expressing FoxP3.

H. Jalahej, M. Borowiec, C. Liew, 2011, International immunology.

Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction

William J. Israelsen, M. V. Vander Heiden, A. Kannt, 2017, Nature Medicine.

Uremic solutes and risk of end stage renal disease in type 2 diabetes

T. Meyer, J. Skupień, R. Mohney, 2014, Kidney international.

Circulating short and medium chain fatty acids are associated with normoalbuminuria in type 1 diabetes of long duration

A. Kostic, A. Smiles, M. Niewczas, 2021, Scientific Reports.

Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes

A. Krolewski, M. Pezzolesi, A. Smiles, 2018, Diabetes.

Biliary tract complications following liver transplantation.

P. Nyckowski, K. Zieniewicz, B. Michałowicz, 2003, Transplantation proceedings.

Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes.

E. Rimm, F. Hu, V. Novelli, 2013, JAMA.

Association Between a Genetic Variant Related to Glutamic AcidMetabolism and Coronary Heart Disease in IndividualsWith Type 2 Diabetes

E. Rimm, F. Hu, V. Novelli, 2013 .

A profile of multiple circulating tumor necrosis factor receptors associated with early progressive kidney decline in Type 1 Diabetes is similar to profiles in autoimmune disorders.

J. Skupień, B. Krolewski, A. Krolewski, 2020, Kidney international.

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.

T. Mayadas, X. Cullere, J. Skupień, 2012, Journal of the American Society of Nephrology : JASN.

Role of podocyte B7-1 in diabetic nephropathy.

M. Rastaldi, A. Krolewski, P. Fiorina, 2014, Journal of the American Society of Nephrology : JASN.

The IL-8-CXCR1/2 axis contributes to diabetic kidney disease.

G. Zuccotti, P. Fiorina, G. Fadini, 2021, Metabolism: clinical and experimental.

Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in Diabetes

V. Nair, M. Bitzer, M. Kretzler, 2021, Journal of the American Society of Nephrology : JASN.

Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.

J. Bonventre, A. Krolewski, V. Vaidya, 2011, Kidney international.

Tuberculosis in patients after renal transplantation remains still a clinical problem.

L. Pączek, M. Niewczas, A. Kwiatkowski, 2002, Transplantation proceedings.

IL 6 but not TNF is linked to coronary artery calcification in patients with chronic kidney disease.

K. Mucha, L. Pączek, M. Gołębiowski, 2019, Cytokine.

Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.

A. Galecki, J. Skupień, K. Duffin, 2017, Kidney international.

Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

A. Krolewski, W. Walker, J. Warram, 2009, American Society of Nephrology. Clinical Journal.

Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes

W. Knowler, R. Nelson, A. Krolewski, 2014, Kidney international.

The NIDDK Diabetic Foot Consortium

A. Veves, M. Tomic-Canic, R. Pop-Busui, 2022, Journal of diabetes science and technology.

Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease

J. Bonventre, A. Krolewski, S. Pennathur, 2017, Diabetes Care.

Circulating Osteoprotegerin in Chronic Kidney Disease and All-Cause Mortality

K. Mucha, L. Pączek, M. Gołębiowski, 2021, International journal of general medicine.

Pyruvate kinase M 2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction

Anja, Thorsten, William J. Israelsen, 2017 .

A Signature of Circulating Inflammatory Proteins and Development of End Stage Renal Disease in Diabetes

Jennifer K. Sun, Hetal S. Shah, C. Ware, 2019, Nature Medicine.

Posttransplantation diabetus mellitus under calcineurin inhibitor.

L. Pączek, M. Michalska, M. Niewczas, 2003, Transplantation proceedings.

Genetic Variant at the GLUL Locus Predicts All-Cause Mortality in Patients With Type 2 Diabetes

Hetal S. Shah, A. Doria, M. Pezzolesi, 2015, Diabetes.

Unbiased Human Kidney Tissue Proteomics Identifies Matrix Metalloproteinase 7 as a Kidney Disease Biomarker

M. Grams, K. Suszták, Hongbo Liu, 2023, Journal of the American Society of Nephrology : JASN.

Cytomegalovirus infection as a common complication following liver transplantation.

P. Nyckowski, K. Zieniewicz, M. Krawczyk, 2003, Transplantation proceedings.

Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes.

A. Krolewski, W. Walker, J. Warram, 2012, American journal of physiology. Renal physiology.

Transcriptome Analysis of Proximal Tubular Cells (HK-2) Exposed to Urines of Type 1 Diabetes Patients at Risk of Early Progressive Renal Function Decline

K. Wanic, W. Ju, M. Kretzler, 2013, PloS one.

Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease

J. Bonventre, A. Krolewski, S. Pennathur, 2017, Diabetes Care.

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

J. Skupień, A. Krolewski, J. Warram, 2011, Journal of the American Society of Nephrology : JASN.

Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

A. Krolewski, W. Walker, J. Warram, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Characterization of human invariant natural killer T cells expressing FoxP3.

H. Jalahej, M. Borowiec, C. Liew, 2011, International immunology.

The impact of experience of a transplantation center on the outcomes of orthotopic liver transplantation.

K. Dudek, P. Nyckowski, K. Zieniewicz, 2003, Transplantation Proceedings.

Long-term Heart Transplant Survival by Targeting the Ionotropic Purinergic Receptor P2x7 Long-term Heart Transplant Survival by Targeting the Ionotropic Purinergic Receptor P2x7 Running Title: Vergani Et Al.; Targeting P2x7r in Heart Transplantation

C. Ricordi, R. Abdi, A. Petrelli, 2022 .